⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15041836 | 0.79 | NOS3 (0.43) | — | |
| SCHEMBL16511823 | 0.76 | NOS3 (0.52) | — | |
| SCHEMBL14933872 | 0.74 | — | — | |
| SCHEMBL16492167 | 0.74 | — | — | |
| SCHEMBL2611021 | 0.70 | UHRF1 (0.50) | — | |
| SCHEMBL12848422 | 0.69 | NOS3 (0.34) | — | |
| SCHEMBL13315484 | 0.67 | LMNA (0.32) | — | |
| SCHEMBL14416666 | 0.67 | NOS3 (0.60) | — | |
| SCHEMBL15614474 | 0.67 | GABRA1 (0.37) | — | |
| SCHEMBL31192244 | 0.67 | NOS3 (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8912203-B2 | 6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders | AFRAXIS HOLDINGS, INC. (US) | 2014-12-16 | — | — | US | disclosed |
| US-20130252966-A1 | 6-(SULFONYLARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS | AFRAXIS, INC. (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130158043-A1 | PAK INHIBITORS FOR THE TREATMENT OF CANCER | AFRAXIS, INC. (US) | 2013-06-20 | — | — | US | disclosed |